Milk powder composition
US-2024074447-A1 · Mar 7, 2024 · US
Equol-producing lactic acid bacteria-containing composition
US10098915B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10098915-B2 |
| Application number | US-201314034824-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 24, 2013 |
| Priority date | Jun 30, 2003 |
| Publication date | Oct 16, 2018 |
| Grant date | Oct 16, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
An equol-producing lactic acid bacteria-containing composition comprises, as an essential component thereof, a lactic acid bacterial strain belonging to the genus Lactococcus having an ability to utilize at least one daidzein compound selected from the group consisting of daidzein glycosides, daidzein, and dihydrodaidzein to produce equol. Such a composition is effective for the prevention and alleviation of malaise inclusive of climacteric disturbance in middle-aged and elderly women for which no effective prophylactic method or alleviating means has heretofore been available.
First claim
Opening claim text (preview).
The invention claimed is: 1. An isolated strain of Lactococcus garvieae 20-92 deposited under accession number FERM BP-10036, wherein said strain is in a lyophilized form. 2. A composition comprising the lyophilized strain of claim 1 . 3. A composition comprising Lactococcus garvieae 20-92 deposited under accession number FERM BP-10036, wherein said composition is in the form of fermented milk or fermented soy milk, said fermented milk or fermented soy milk having been fermented by said Lactococcus garvieae 20-92.
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10098915B2 cover?
- An equol-producing lactic acid bacteria-containing composition comprises, as an essential component thereof, a lactic acid bacterial strain belonging to the genus Lactococcus having an ability to utilize at least one daidzein compound selected from the group consisting of daidzein glycosides, daidzein, and dihydrodaidzein to produce equol. Such a composition is effective for the prevention an…
- Who is the assignee on this patent?
- Otsuka Pharma Co Ltd
- What technology area does this patent fall under?
- Primary CPC classification A23C9/123. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).